RBC Capital analyst Nik Modi lowered the firm’s price target on Edgewell Personal Care (EPC) to $43 from $48 and keeps an Outperform rating on the shares. The company reported Q1 results that fell modestly short of consensus with prevailing themes generally consistent with recent results, even though its external headwinds are becoming “incrementally more meaningful” as seen with other HPC – Home and Personal Care – peers, the analyst tells investors in a research note. RBC adds that while Edgewell’s FY25 organic growth guidance remains unchanged, its profitability outlook now declines as a result of negative FX.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on EPC:
- Edgewell Personal Care price target lowered to $40 from $53 at Canaccord
- Edgewell Personal Care price target lowered to $32 from $35 at Morgan Stanley
- Edgewell Personal Care price target lowered to $35 from $37 at Wells Fargo
- Edgewell Personal Care: Attractive Buy Rating Amidst Low Valuation and Future Growth Prospects
- Edgewell Personal Care price target lowered to $30 from $33 at Barclays